IntelGenx Technologies Corp.
IGXTDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001098880
IntelGenx Technologies Corp. was delisted in 2024; its insiders filed their last Form 4 on May 3, 2024; 1 institution reported holding it in 13F filings for Q1 2024, worth $414 in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in IntelGenx Technologies Corp. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- −1 vs. Q3 2021
- Shares held
- 0
- −5.00K (−100.0%) vs. Q3 2021
- Total value
- $0
- −$2.00K (−100.0%) vs. Q3 2021
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $414 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 1 | $900 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 1 | $2.00K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding IntelGenx Technologies Corp.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Monetary Management Group Inc | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |